Emodin enhances osteogenesis and inhibits adipogenesis

BMC Complementary and Alternative Medicine

Zheng-Mao Lu¹  Yang-Quan Hao¹  Pu-wei Yuan¹  Feng Yang¹ 

[1] Department of Orthopedics, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xi’an 712083, PR China

关键词: Molecular mechanism;    Mesenchymal stem cell;    Adipogenesis;    Osteogenesis;    Emodin;   

Others  :  1220249
DOI  :  10.1186/1472-6882-14-74

 received in 2013-08-27, accepted in 2014-02-11,  发布年份 2014

【 摘 要 】

Background

It has been suggested that the formation of osteoblasts in bone marrow is closely associated with adipogenesis, and the balance between osteogenesis and adipogenesis differentiation of MSCs (mesenchymal stem cells) is disrupted in osteoporosis. In order to improve the treatment of osteoporosis, available agents with roles of regulating the balance is highly desirable. Emodin is a natural anthraquinone derivative extracted from Chinese herbs, which have been used to treat bone diseases for thousands of years. However, the underlying molecular mechanisms of emodin in modulating osteogenesis and adipogenesis remain poorly understood.

Methods

The molecular mechanisms of emodin on the processes of osteogenesis and adipogenesis in ovariectomized mouse and BMSCs (bone marrow mesenchymal stem cells) have been studied. We have analyzed the effects of emodin in vivo and in vitro. Female ICR mice were assigned to three groups: sham group, ovariectomy group, emodin group. Efficacy was evaluated by H&E, immunohistochemical assay and Micro-CT. In vitro, we analyze the effect of emodin—at concentrations between 0.1 μM and 10 μM-on the processes of inducing osteogenesis and inhibiting adipogenesis in BMSCs by ALP, Oil red O staining, real time RT-PCR and western blot.

Results

As our experiment shows that emodin could increase the number of osteoblast, BMD (bone mineral density), BV/TV (trabecular bone volume fraction), Tb.N (trabecular number) and Conn.D (connectivity density) of OVX (ovariectomized) mice and decrease the bone marrow fat tissue and adipocytes. The genes and proteins expression of osteogenesis markers, such as Runx2, osterix, collagen type I, osteocalcin, or ALP were up-regulated. While, the genes and proteins involved in adipogenesis, PPARγ, C/EBPα and ap2 were down-regulated.

Conclusion

It proves that emodin inhibits adipocyte differentiation and enhances osteoblast differentiation from BMSCs.

【 授权许可】

   
2014 Yang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Hartsock RJ, Smith EB, Petty CS: Normal variations with aging of the amount of hematopoietic tissue in bone marrow from the anterior iliac crest: a study made from 177 cases of sudden death examined by necropsy. Am J Clin Pathol 1965, 43:326-331.
• [2]Meunier P, Aaron J, Edouard C, Vignon G: Osteoporosis and the replacement of cell populations of the marrow by adipose tissue: a quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 1971, 80:147-154.
• [3]Juan PR, Astudillo P, Ríos S, Seitz G, Pino AM: Adipogenesis and osteoporosis. Rev Méd Chile 2009, 137:827-836.
• [4]Duque G: Bone and fat connection in aging bone. Curr Opin Rheumatol 2008, 20:429-434.
• [5]Feng Y, Huang SL, Dou W, Zhang S, Chen JH, Shen Y, Shen JH, Leng Y: Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice. Br J Pharmacol 2010, 161:113-126.
• [6]Matsuda H, Shimoda H, Morikawa T, Yoshikawa M: Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structure-requirement of hydroxyanthraquinones for estrogenic activity. Bioorg Med Chem Lett 2001, 11:1839-1842.
• [7]Ghosh S, Das Sarma M, Patra A, Hazra B: Anti-inflammatory and anticancer compounds isolated from Ventilago madraspatana Gaertn., Rubia cordifolia Linn. and Lantana camara Linn. J Pharm Pharmacol 2010, 62:1158-1166.
• [8]Dong MX, Jia Y, Zhang YB, Li CC, Geng YT, Zhou L, Li XY, Liu JC, Niu YC: Emodin protects rat liver from CCl(4)-induced fibrogenesis via inhibition of hepatic stellate cells activation. World J Gastroenterol 2009, 15:4753-4762.
• [9]Hwang JK, Noh EM, Moon SJ, Kim JM, Kwon KB, Park BH, You YO, Hwang BM, Kim HJ, Kim BS, Lee SJ, Kim JS, Lee YR: Emodin suppresses inflamm -atory responses and joint destruction in collagen-induced arthritic mice. Rheumatology 2013, 52(9):1583-1591.
• [10]Lee SU, Shin HK, Min YK, Kim SH: Emodin accelerates osteoblast differentiation through phosphatidylinositol 3-kinase activation and bone morphogenetic protein-2 gene expression. Int Immunopharmacol 2008, 8:741-747.
• [11]Zhang C, Teng L, Shi Y, Jin J, Xue Y, Shang K, Gu J: Effect of emodin on proliferation and differentiation of 3 T3-L1 preadipocyte and FAS activity. Chin Med J 2002, 115:1035-1038.
• [12]Yang YQ, Yang GS: Effect of emodin on proliferation and differentiation of rat preadipocytes. Zhongguo Zhong Yao Za Zhi 2007, 32(5):424-427.
• [13]Jilka RL, Weinstein RS, Takahashi K, Parfitt AM, Manolagas SC: Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest 1996, 97:1732-1740.
• [14]Verma S, Rajaratnam JH, Denyon J, Hoyland JA, Byers RJ: Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol 2002, 55:693-698.
• [15]Rosen CJ, Bouxsein ML: Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2006, 2:35-43.
• [16]Rodríguez JP, Montecinos L, Ríos S, Reyes P, Martínez J: Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring the adipogenic differentiation. J Cell Biochem 2000, 79:557-565.
• [17]Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsety G: A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 1999, 13:1025-1036.
• [18]Komori T: Regulation of bone development and maintenance by Runx2. Front Biosci 2008, 13:898-903.
• [19]Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B: The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
• [20]Komori T: Requisite roles of Runx2 and Cbfb in skeletal development. J Bone Miner Metab 2003, 21:193-197.
• [21]Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B: Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPARgamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 2004, 3:379-389.
• [22]Martin RB, Zissimos SL: Relationships between marrow fat and bone turnover in ovariectomized and intact rats. Bone 1991, 12:123-131.
• [23]Rosen ED, MacDougald OA: Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006, 7:885-896.
• [24]Lu D, Carson DA: Repression of β-catenin signaling by PPARγ ligands. Eur J Pharmacol 2010, 636:198-202.
• [25]Jeon MJ, Kim JA, Kwon SH, Kim SW, Park KS, Park SW, Kim SY, Shin CS: Activation of peroxisome proliferator-activated receptor-γ inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J Biol Chem 2003, 278:23270-23277.